Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial
- 1 June 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 205 (6), 1605-1611
- https://doi.org/10.1097/ju.0000000000001602
Abstract
Purpose: Concern for discordance between clinical staging and final pathology drives current management of patients deemed appropriate candidates for radical cystectomy (RC). Thus, we set out to prospectively investigate reliability and shortcomings of cystoscopic evaluation in RC candidates. Materials and Methods: Patients undergoing RC for urothelial carcinoma (UC) were enrolled in a prospective single-arm study to evaluate reliability of Systematic Endoscopic Evaluation (SEE) in predicting pT0 UC (NCT02968732). SEE consisted of cystoscopy and tissue sampling at the time of RC. SEE results were compared to RC pathology. The primary endpoint was the negative predictive value (NPV) of SEE findings in predicting RC pathology. Results: 61 patients underwent SEE and RC. Indications included muscle-invasive bladder cancer (MIBC) in 42 (68.9%) and high-risk non-muscle invasive bladder cancer (NMIBC) in 19 (31.1%). Thirty-eight (62.3%, 90.5% of MIBC patients) received neoadjuvant chemotherapy (NAC). On SEE, 31 (50.8%) patients demonstrated no visual nor biopsy-based evidence of disease (seeT0), yet 16/31 (51.6%) harbored residual disease (>pT0), including eight (8/31, 25.8%) with residual ≥pT2 disease upon RC. The NPV of SEE predicting a pT0 bladder was 48.4% (CI: 30.2–66.9%), which was below our pre-specified hypothesis, and thus the trial was stopped for futility. Conclusions: Approximately 1 of 4 patients with seeT0 at the time of RC harbored residual MIBC. These prospective data definitively confirm major limitations of endoscopic assessment for pT0 bladder cancer. Future work should focus on novel imaging and biomarker strategies to optimize pre-RC evaluations for improved decision-making regarding bladder preservation.Keywords
This publication has 27 references indexed in Scilit:
- ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the BladderEuropean Urology, 2012
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2012
- Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?Virchows Archiv A Pathological Anatomy and Histopathology, 2012
- FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder CancerEuropean Urology, 2010
- Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder CancerUrology, 2009
- Opposing ViewsJournal of Urology, 2009
- Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical CystectomyEuropean Urology, 2007
- Cancer Specific Outcomes in Patients With PT0 Disease Following Radical CystectomyJournal of Urology, 2006
- Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survivalCancer, 2005
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003